Abstract
Purpose
This study describes the distribution and the trends of cervical abnormalities in Israel, based on Pap smear results.
Methods
A retrospective analysis of cervical smears received by the Central Pathology Laboratory of Maccabi Healthcare Services between January 2005 and December 2010.
Results
In total, 711,541 Pap smears were screened in the study period. Cytological abnormalities were observed in 4.78 % of the total smears screened. An increase was observed in the rate of positive results from 2.63 % in 2005 to 6.78 % in 2010 (p = 0.0026). The cervical abnormalities in the study period distributed as follows: atypical squamous cell (ASC)—2.72 %, low-grade squamous intraepithelial lesion (LSIL)—1.54 %, high-grade squamous intraepithelial lesion (HSIL)—0.34 %, squamous cell carcinoma—0.01 %, atypical glandular cells (AGC)—0.10 %, adenocarcinoma in situ (AIS)—0.06 % and invasive adenocarcinoma—0.01 %. The increase was statistically significant for ASC (p = 0.0028), LSIL (p = 0.0069) and for HSIL (p = 0.0260). The mean ages at diagnosis of women with ASCUS, LSIL, HSIL, squamous cell carcinoma, AGC, AIS and adenocarcinoma were 37.8, 33.2, 38.6, 55.4, 41.1, 49.9 and 57.1 years, respectively.
Conclusions
The increase in the rate of squamous cell abnormalities demonstrated in this study emphasizes the need of implementing an education and a screening program among Israeli women. HPV vaccine, sexual behavior, cytology performance and HPV test are primary and secondary prevention tools which may reduce morbidity and mortality in the future. In addition, based on the age at diagnosis of the different pathologies, the age group in which Pap test is performed in Israel should be expanded from 35–54 to 25–65 years.
Similar content being viewed by others
References
Globocan 2008. Cervical Cancer Incidence and Mortality Worldwide in 2008 Summary. Cancer fact sheet. Available at http://globocan.iarc.fr/factsheets/cancers/cervix.asp
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19
Michalas SP (2000) The Pap test: George N. Papanicolaou (1883–1962). A screening test for the prevention of cancer of uterine cervix. Eur J Obstet Gynecol Reprod Biol 90:135–138
Stack PS (1997) Pap smears. Still a reliable screening tool for cervical cancer. Postgrad Med 101(207–8):211–214
The American College of Obstetricians and Gynecologists. Frequently Asked Questions. Available at http://www.acog.org/~/media/For%20Patients/faq085.pdf?dmc=1&ts=20121020T0952483851
Israel Center for Disease Control (2008) Cancer in Israel: trends in incidence and mortality, 1982–2002, and selected updates data, 2004. Publication no. 310. pp 199–205
Israeli Obstetric and Gynecologic society. Position Paper no. 7. Pap test as screening test for early detection of cervix cancer. Available at http://www.mrm.org.il/multimedia/upl_doc/doc_160308_30359.pdf
Holschneider CH (2008) Human papillomavirus and the management of the abnormal Pap test. In: Gibbs RS, Karlan BY, Haney AF (eds) Danforth’s obstetrics and gynecology, 10th edn. Lippincott Williams & Wilkins, Philadelphia, pp 989–1001
Margolis KL, Carson LF, Setness PA, Stanley MW, Henry-Stanley MJ, Beneke J, Linzie B, McGlennen RC (1999) Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study. Arch Fam Med 8:433–439
Roberts JM, Thurloe JK, Bowditch RC, Hyne SG, Greenberg M, Clarke JM, Biro C (2007) A three-armed trial of the ThinPrep Imaging System. Diagn Cytopathol 35:96–102
Israeli Social Security. Periodical Surveys—Membership in Health Maintenance organizations
Wolfendale MR, King S, Usherwood MM (1983) Abnormal cervical smears: are we in for an epidemic? Br Med J (Clin Res Ed) 287:526–528
Nokiani FA, Akbari H, Rezaei M, Madani H, Ale Agha ME (2008) Cost-effectiveness of pap smear in Kermanshah, Iran. Asian Pac J Cancer Prev 9:107–110
Mehmetoglu HC, Sadikoglu G, Ozcakir A, Bilgel N (2010) Pap smear screening in the primary health care setting: a study from Turkey. N Am J Med Sci 2:467–472
Schwarz PJ, Fasal E, Simmons ME (1981) 12-county program: screening of 34,318 women for cervical cancer in California, 1975–78. Public Health Rep 96:547–554
Giorgi Rossi P, Ricciardi A, Cohet C, Palazzo F, Furnari G, Valle S, Largeron N, Federici A (2009) Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy. BMC Public Health 9:71
Bal MS, Goyal R, Suri AK, Mohi MK (2012) Detection of abnormal cervical cytology in Papanicolaou smears. J Cytol 29:45–47
Insinga RP, Glass AG, Rush BB (2004) Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol 191:105–113
Banik U, Bhattacharjee P, Ahamad SU, Rahman Z (2011) Pattern of epithelial cell abnormality in Pap smear: a clinicopathological and demographic correlation. Cytojournal 8:8
Altaf FJ, Mufti ST (2012) Pattern of cervical smear abnormalities using the revised Bethesda system in a tertiary care hospital in Western Saudi Arabia. Saudi Med J 33:634–639
Okonda S, Wright C, Michelow P (2009) The status of cervical cytology in Swaziland, Southern Africa: a descriptive study. Cytojournal 6:14
Sadan O, Schejter E, Ginath S, Bachar R, Boaz M, Menczer J, Glezerman M (2004) Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women. Arch Gynecol Obstet 269:188–191
Israel National Cancer Registry; Israel Center for Disease Control, Ministry of Health (2007) Geographical mapping of cancer in Israel according to the different districts 2001–2005. Publication 311. Available at http://www.old.health.gov.il/download/pages/mipui_4a15-10-07.pdf
Cannistra SA, Niloff JM (1996) Cancer of the uterine cervix. N Engl J Med 334:1030–1038
American Congress of Obstetricians and Gynecologists (2012) New cervical cancer screening recommendations from the U.S. Preventive Services Task Force and the American Cancer Society/American Society for Colposcopy and Cervical Pathology/American Society for Clinical Pathology. Available at http://www.acog.org/About_ACOG/Announcements/New_Cervical_Cancer_Screening_Recommendations
Peterson NB, Murff HJ, Cui Y, Hargreaves M, Fowke JH (2008) Papanicolaou testing among women in the southern United States. J Womens Health (Larchmt) 17:939–946
Hatcher J, Studts CR, Dignan MB, Turner LM, Schoenberg NE (2011) Predictors of cervical cancer screening for rarely or never screened rural Appalachian women. J Health Care Poor Underserved 22:176–193
Swan J, Breen N, Graubard BI, McNeel TS, Blackman D, Tangka FK, Ballard-Barbash R (2010) Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer 116:4872–4881
Reyes-Ortiz CA, Markides KS (2010) Socioeconomic factors, immigration status, and cancer screening among Mexican American women aged 75 and older. Health Care Women Int 31:1068–1081
Nguyen TT, McPhee SJ, Nguyen T, Lam T, Mock J (2002) Predictors of cervical Pap smear screening awareness, intention, and receipt among Vietnamese-American women. Am J Prev Med 23:207–214
Raz R, Shavit O, Stein M, Cohen R, Schejter E, Chodick G, Shalev V (2012) Uptake of Pap smears among women in a large Israeli HMO between 2006 and 2008. Public Health 126:594–599
Beerman H, van Dorst EB, Kuenen-Boumeester V, Hogendoorn PC (2009) Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program. Gynecol Oncol 112:572–576
Shepherd J, Peersman G, Weston R, Napuli I (2000) Cervical cancer and sexual lifestyle: a systematic review of health education interventions targeted at women. Health Educ Res 15:681–694
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was performed in partial fulfillment of the requirements for a Ph.D. degree of Ravit Bassal, Sackler Faculty of medicine, Tel Aviv University, Israel.
Rights and permissions
About this article
Cite this article
Bassal, R., Schejter, E., Bachar, R. et al. Cervical Pap screening among Israeli women, 2005–2010. Arch Gynecol Obstet 289, 615–622 (2014). https://doi.org/10.1007/s00404-013-3045-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-013-3045-z